Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Director · Executive Chairman | December 16, 2024 | December 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date December 16, 2024 · Filed December 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,973 |
Reported balance
After 2024-12-16 transaction · row 1
1 source rowRow 1 · 2024-12-16 · Sale · Disposed 13,609 · Balance 23,973 F1: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $33.34 to $33.55. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $33.34 to $33.55. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2024 Filed Dec 17, 2024 16:28 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 13,609 | $33.44 | $455,084.96 |
DisclosureSEC source: 0001304492-24-000140 · wk-form4_1734470912.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,973 F1 · kind: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $33.34 to $33.55. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 20:31 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000138 · wk-form4_1733967069.xml · derivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2025-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shares are fully vested and the option would have expired by its terms on January 29, 2025. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 20:31 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 76,391 | $34.05 | $2,601,113.55 |
DisclosureSEC source: 0001304492-24-000138 · wk-form4_1733967069.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,582 F1 · price: This price reflects the closing price of the Issuer's Common Stock on the Nasdaq Capital Market on December 9, 2024. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 20:31 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 90,000 | $25.00 | $2,250,000.00 |
DisclosureSEC source: 0001304492-24-000138 · wk-form4_1733967069.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2023 Filed May 22, 2023 18:54 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,974 | $31.11 | $61,411.14 |
DisclosureSEC source: 0001209191-23-031595 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,973 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 18:04 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $22.75 | $0.00 |
DisclosureSEC source: 0001209191-23-018991 · doc4.xml · derivative · entry 7 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,945 Underlying: Common Stock · 20,000 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 18:04 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018991 · doc4.xml · derivative · entry 6 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 18:04 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 40,000 | $30.01 | $1,200,500.00 |
DisclosureSEC source: 0001209191-23-018991 · doc4.xml · nonDerivative · entry 4 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,947 F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.77 to $30.28. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 18:04 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 5,000 | $30.29 | $151,473.00 |
DisclosureSEC source: 0001209191-23-018991 · doc4.xml · nonDerivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,947 F1 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.79 to $30.56. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 18:04 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 20,000 | $22.75 | $455,000.00 |
DisclosureSEC source: 0001209191-23-018991 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 18:04 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 20,000 | $20.00 | $400,000.00 |
DisclosureSEC source: 0001209191-23-018991 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 18:36 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 154,203 | $0.00 Strike: $49.39 | $0.00 |
DisclosureSEC source: 0001209191-22-060105 · doc4.xml · derivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,203 Underlying: Common Stock · 154,203 shares Expires 2032-12-02 F1 · derivative.exercise_date: 25% of the option shares vest and become exercisable on December 2, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter. Read SEC document |
| October 12, 2022 Filed Mar 15, 2023 18:04 UTC | Anterix Inc. ATEX · Entity 4597 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018991 · doc4.xml · nonDerivative · entry 5 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,947 F3 · kind: These transactions represent a charitable contribution by the Reporting Person. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 18:13 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,366 | $45.40 | $107,416.40 |
DisclosureSEC source: 0001209191-22-045295 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,947 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 19:09 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001209191-22-037622 · doc4.xml · derivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 25,000 shares Expires 2025-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 19:09 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 25,000 | $40.03 | $1,000,775.00 |
DisclosureSEC source: 0001209191-22-037622 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,313 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $40.00 to $40.595. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 19:09 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 25,000 | $25.00 | $625,000.00 |
DisclosureSEC source: 0001209191-22-037622 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:37 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,974 | $42.47 | $83,835.78 |
DisclosureSEC source: 0001209191-22-033341 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,313 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| March 15, 2022 Filed Mar 22, 2022 20:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020648 · doc4.xml · derivative · entry 4 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 25,000 shares Expires 2025-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| March 15, 2022 Filed Mar 22, 2022 20:00 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 18,405 | $56.25 | $1,035,336.47 |
DisclosureSEC source: 0001209191-22-020648 · doc4.xml · nonDerivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,287 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.99 to $56.575. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2022 Filed Mar 22, 2022 20:00 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 6,595 | $55.37 | $365,132.18 |
DisclosureSEC source: 0001209191-22-020648 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,692 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $54.76 to $55.75. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2022 Filed Mar 22, 2022 20:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 25,000 | $25.00 | $625,000.00 |
DisclosureSEC source: 0001209191-22-020648 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 19:59 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070083 · doc4.xml · derivative · entry 5 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 25,000 shares Expires 2025-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 19:59 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 7,155 | $56.47 | $404,042.85 |
DisclosureSEC source: 0001209191-21-070083 · doc4.xml · nonDerivative · entry 4 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,287 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.515 to $56.86. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 19:59 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 12,162 | $55.04 | $669,403.78 |
DisclosureSEC source: 0001209191-21-070083 · doc4.xml · nonDerivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,442 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $54.50 to $55.50. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 19:59 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 5,683 | $54.00 | $306,890.52 |
DisclosureSEC source: 0001209191-21-070083 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,604 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $53.49 to $54.475. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 19:59 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 25,000 | $25.00 | $625,000.00 |
DisclosureSEC source: 0001209191-21-070083 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:08 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 377 | $57.34 | $21,616.43 |
DisclosureSEC source: 0001209191-21-056734 · doc4.xml · nonDerivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,287 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $57.25 to $57.55. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:08 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 13,869 | $56.30 | $780,783.09 |
DisclosureSEC source: 0001209191-21-056734 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,664 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $56.05 to $56.895. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 19:08 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 2,649 | $55.53 | $147,096.32 |
DisclosureSEC source: 0001209191-21-056734 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,533 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $55.10 to $55.895. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 18:50 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 65,595 | $0.00 Strike: $60.92 | $0.00 |
DisclosureSEC source: 0001209191-21-055208 · doc4.xml · derivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,595 Underlying: Common Stock · 65,595 shares Expires 2031-09-07 F1 · derivative.exercise_date: 33 1/3% of the option shares vest and become exercisable on September 7, 2022 with the remaining shares vesting in 2 equal annual installments thereafter. Read SEC document |
| September 07, 2021 Filed Jun 8, 2022 21:05 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 65,768 | $0.00 Strike: $60.92 | $0.00 |
DisclosureSEC source: 0001209191-22-035272 · doc4a.xml · derivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,768 Underlying: Common Stock · 65,768 shares Expires 2031-09-07 F1 · shares: The prior Form 4 incorrectly reported the option grant for 65,595 shares. F2 · derivative.exercise_date: 33 1/3% of the option shares vest and become exercisable on September 7, 2022 with the remaining shares vesting in 2 equal annual installments thereafter. F1 · derivative.underlying_shares: The prior Form 4 incorrectly reported the option grant for 65,595 shares. F1 · balance_after: The prior Form 4 incorrectly reported the option grant for 65,595 shares. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 18:09 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,365 | $56.49 | $133,598.85 |
DisclosureSEC source: 0001209191-21-052008 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,182 F2 · kind: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units granted August 2018. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 18:09 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 5,000 | $56.50 | $282,485.00 |
DisclosureSEC source: 0001209191-21-052008 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,547 F1 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $56.28 to $57.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 17:48 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 18,170 | $60.00 | $1,090,200.00 |
DisclosureSEC source: 0001209191-21-045601 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,547 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units granted June 2020. Read SEC document |
| June 07, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,209 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · derivative · entry 9 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 13,209 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| June 07, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 13,209 | $50.35 | $665,083.72 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · nonDerivative · entry 6 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,717 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $50.00 to $50.66. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 13,209 | $20.00 | $264,180.00 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · nonDerivative · entry 5 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,672 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · derivative · entry 8 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,209 Underlying: Common Stock · 6,672 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 6,672 | $50.03 | $333,804.83 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · nonDerivative · entry 4 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,717 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $49.75 to $50.24. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 6,672 | $20.00 | $133,440.00 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · nonDerivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,785 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · derivative · entry 7 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,881 Underlying: Common Stock · 11,785 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 11,785 | $49.74 | $586,176.47 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,717 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $49.20 to $50.34. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 18:00 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 11,785 | $20.00 | $235,700.00 |
DisclosureSEC source: 0001209191-21-038738 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 24, 2021 19:44 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,333 | $48.58 | $64,751.81 |
DisclosureSEC source: 0001209191-21-035532 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,717 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $48.50 to $48.725. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:33 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 31,667 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011520 · doc4.xml · derivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,666 Underlying: Common Stock · 31,667 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:33 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 31,667 | $40.16 | $1,271,901.89 |
DisclosureSEC source: 0001209191-21-011520 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,250 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $40.00 to $40.795. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:33 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 31,667 | $20.00 | $633,340.00 |
DisclosureSEC source: 0001209191-21-011520 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2020 Filed May 3, 2021 20:50 UTC | Anterix Inc. ATEX · Entity 4597 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029650 · doc5.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,050 F1 · kind: These transactions represent gifts or charitable contributions by the Reporting Person. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 18:13 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 31,667 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-20-065071 · doc4.xml · derivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 31,667 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.